Valuation: Navamedic ASA

Market Cap 402M 41.01M 35.89M 33.08M 30.66M 58.2M 3.89B 59.14M 397M 154M 1.92B 154M 151M 6.64B P/E 2026 *
-305x
P/E 2027 * 37.6x
Enterprise Value 522M 53.26M 46.61M 42.96M 39.82M 75.58M 5.06B 76.8M 515M 200M 2.49B 200M 196M 8.62B EV / Sales 2026 *
0.89x
EV / Sales 2027 * 0.76x
Free-Float
74.67%
Yield 2026 *
-
Yield 2027 * -
1 day-2.33%
1 week+2.45%
Current month+2.45%
1 month-1.18%
3 months-14.97%
6 months-23.52%
Current year-29.62%
1 week 16.15
Extreme 16.15
17.45
1 month 15.7
Extreme 15.7
18
Current year 15.7
Extreme 15.7
24.5
1 year 15.7
Extreme 15.7
27.9
3 years 15.7
Extreme 15.7
43.9
5 years 15.7
Extreme 15.7
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2019
Director of Finance/CFO - 01/01/2026
Compliance Officer - -
Director TitleAgeSince
Chairman 66 -
Director/Board Member 60 01/06/2024
Director/Board Member - 01/06/2023
Date Insider Type Main position Quantity % Market Cap.
19/12/24Buy

Chief Operating Officer

10,267 0.0581%
09/09/24Fiscal year

Executive/Senior Manager

75,000 0.4302%
09/09/24Fiscal year

Chief Executive Officer

80,000 0.4589%
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%+2.45%-23.86%-56.27% 41.85M
+2.96%+3.01%+59.87%+173.31% 1,070B
+3.05%+5.23%+72.11%+67.81% 624B
-0.04%+1.20%+35.72%+87.93% 450B
+2.14%-2.07%+27.62%+22.57% 328B
+1.36%+0.17%+29.90%+49.33% 284B
+1.98%+4.08%-25.78%-39.02% 217B
+0.45%+1.65%+25.65%+68.35% 198B
+5.21%+7.93%+21.99%+83.23% 161B
+1.48%-0.04%-4.64%-32.25% 135B
Average +1.74%+1.24%+21.86%+42.50% 346.75B
Weighted average by Cap. +2.35%+0.74%+41.85%+87.34%

Financials

2026 *2027 *
Net sales 588M 60.02M 52.52M 48.41M 44.87M 85.17M 5.7B 86.54M 580M 226M 2.81B 225M 220M 9.72B 643M 65.7M 57.49M 52.98M 49.11M 93.22M 6.24B 94.73M 635M 247M 3.08B 247M 241M 10.64B
Net income -1.5M -153K -134K -123K -114K -217K -14.49M -220K -1.48M -574K -7.15M -573K -561K -24.71M 10.7M 1.09M 956K 881K 817K 1.55M 104M 1.58M 10.56M 4.11M 51.17M 4.1M 4.01M 177M
Net Debt 120M 12.25M 10.72M 9.88M 9.16M 17.39M 1.16B 17.67M 118M 46.08M 574M 46M 45M 1.98B 87.4M 8.92M 7.81M 7.2M 6.67M 12.66M 847M 12.87M 86.3M 33.56M 418M 33.5M 32.78M 1.44B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
07/07/26 NOK 16.75 -2.33% 1,522
06/07/26 NOK 17.15 +0.88% 10,304
03/07/26 NOK 17.00 +4.94% 30,323
02/07/26 NOK 16.20 -0.92% 147
01/07/26 NOK 16.35 0.00% 5,482
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
17.15NOK
Average target price
23.50NOK
Spread / Average Target
+37.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock